SEC Form 4 · accession 0001275292-17-000004
Oncolix, Inc. · ONCX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
J Donald Payne
Officer — Secretary · Director
Period of report
Sep 26, 2017
Accepted (ET)
Sep 26, 2017 · 10:26 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001584137
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 26, 2017 | M | 200,000 | $0.005 | A | 2,028,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to acquire Common StockF1 | $0.005 | Sep 26, 2017 | M | 200,000 | D | Aug 3, 2017 | Apr 25, 2021 | Common Stock | 300,000 | 1,400,000 | D |
Explanation of responses
- F1On September 26, 2017 Mr. Payne exercised an option to acquire 200,00 shares of Common Stock at $0.005 per share. After the exercise, there were 300,000 shares available under this grant and options to acquire 1,400,000 shares of Common Stock in total. Including shares of Common Stock issuable upon conversion of Series A Preferred Stock or exercise of Warrants to acquire Series A Preferred Stock, the number of shares of Common Stock beneficial owned was 2,028,000.